Möchten Sie immer auf dem neuesten Stand bleiben?

Plus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026 Affirms 2026 guidance on key milestones Reports positive CNSide® commercial progress HOUSTON, June ...

Proposed Alliance with an Established Strategic Partner Operating in the Sustainable Food and Agriculture Sector Expected to Expand Utilization of Edible Garden's National Distribution Platform,...

TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Blossom Gold Inc. (formerly, 1290448 B.C. Ltd.) (“Blossom” or the “Company”) (TSX: BGAU) is pleased to announce initial drill results from its 2026...

AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease ACI-24 anti-Abeta active immunotherapy generally safe and well tolerated in first three...

Factorial publishes its first shareholder letter, highlighting a decade of solid-state battery innovation and its path to commercialization.

The Residence Inn by Marriott Boston Marlborough, Massachusetts, has undergone a complete renovation of all guest rooms and public spaces.

Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study Nexviazyme met its primary endpoint, participants alive and free of invasive ventilation, in...

Fortuna delivers robust Diamba Sud Feasibility Study in Senegal with an after-tax IRR of 60% and $1B NPV5% at $3,500/oz gold.

HAMILTON, BERMUDA, June 29, 2026 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announced that it has identified and will implement a proactive design upgrade for its two newbuildings...

IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26 FDA’s decision follows positive Phase 1 results for GT-02287 in both healthy...